265 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
obligations; and
diversion of management and employee attention and resources from key business activities and risk management outside of COVID-19 … , in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for the Company
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
; and
diversion of management and employee attention and resources from key business activities and risk management outside of COVID-19 response efforts … of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for the Company. The Company’s security
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
, and vendors to do the same in regard to their own obligations; and
diversion of management and employee attention and resources from key business … . Such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate
8-K
EX-10.1
rbaeugoh4aywv
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
wsx2121 qf6
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
424B4
wo13x
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
y1to k4g5d
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
ptv xvtn1t
17 Nov 23
Prospectus supplement
5:00pm
424B4
h1g 5lxc7g
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B3
vbyc4rxz4yxsop e35
17 Aug 23
Prospectus supplement
5:00pm